TAS-102 Extends Overall Survival in Refractory Metastatic Colorectal Cancer
Results of the RECOURSE trial may make the combination agent a new standard of care in advanced disease.
All articles by Greg Otis
Misdiagnosis of HER2-Negative Metastatic Breast Cancer May Lead to Suboptimal Treatment
Inaccurate test results falsely classify some women as HER2 negative, denying them the benefits of targeted treatment.
3D Mammography Improves Cancer Detection Rate, Reduces Recall Rate
A study that included almost half a million mammograms suggests that tomosynthesis combined with digital mammography may become the new standard of care.
“Remarkable” Response to Virotherapy for Multiple Myeloma
For the first time, systemically administered virotherapy has been used to treat disseminated cancer.
Patient Deaths Cloud Adjuvant Ipilimumab Trial
Ipilimumab significantly reduced the risk of melanoma recurrence after resection, but drug toxicity will limit its use.
Fusion-guided Prostate Biopsy More Accurate Than Standard
New techniques for detecting prostate cancer are finding disease more often and call into question the criteria for active surveillance.
No Cancer Prevention Benefit From Organic Food
A prospective survey found no reduction in cancer incidence in women eating organic food, but there’s more to the story.
VEGF Inhibitors Trigger Hypertension, Possible Cardiovascular Events
Antiangiogenic cancer therapies elevate blood pressure in almost all patients, and put some at risk for stroke and myocardial infarction.
Brachytherapy: An Underused Option for Prostate Cancer?
Use of a cost-effective treatment is declining steadily while more expensive therapies grow in popularity.
Chronic Inflammation More Common in Aggressive Prostate Cancer
Inflammation and prostate cancer appear to be linked, but a causative connection has not yet been proven.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...